Name: VMD Income Statement - Viemed Healthcare Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

VMD - Viemed Healthcare, Inc.

USD | NASDAQ

VMD Income Statement - Viemed Healthcare Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18
Revenues
Revenues	75.4	76.2	71.9	63.1	59.1	60.7	58.0	55.0	50.6	50.7	49.4	43.3	39.6	37.5	35.8	33.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Revenues
Revenues	286.6	270.3	224.3	183.0	138.8	117.1	131.3	80.3	64.5
Cost of Revenue	121.6	114.8	91.1	70.2	54.2	43.7	51.2	24.3	16.7
Gross Profit	165.0	155.5	133.2	112.8	84.7	73.4	80.1	56.0	47.8
Operating Expenses
Research & Development	2.8	3.0	3.1	2.8	2.7	2.1	1.1	0.8	0.0
Selling General & Administrative	127.7	121.4	106.2	87.9
Operating Income
Operating Income	23.4	22.9	17.9	14.3	8.3	11.6	26.8	8.9	10.1
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-
Tax & Net
Income Tax Expense	6.7	6.4	4.8	4.1	2.8	3.4	(5.2)	0.3	0.2
Net Income From Continuing Ops	15.4	15.4	11.4	10.2
Per Share
EPS Basic	0.39	0.38	0.29	0.27	0.16	0.23	0.81	0.23	0.25
EPS Diluted	0.37	0.37	0.28	0.25	0.16
Supplementary Data
EBITDA	53.0	51.6	43.3	36.2	23.9	22.9	36.4	15.3	13.8
EBIT	23.4	22.9	17.9	14.3	8.3	11.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Income
Operating Income	4.3	8.4	5.6	5.1	3.8	6.5	5.6	3.6	2.2	5.3	4.2	2.9	1.9	3.5	1.5	1.0	2.2	4.7	2.9	2.7	1.3	5.3	4.0	12.9	4.6	2.7	2.2	1.7	2.3	-	2.7	2.6	-

Per Share
EPS Basic	0.07	-	0.09	0.08	0.07	-	0.10	0.04	0.04	-	0.08	0.06	0.04	-	0.03	0.02	0.04	-	0.05	0.04	0.04	-	0.07	0.50	0.11	-	0.08	0.04	0.05	-	0.06	0.06	-
EPS Diluted	0.06	-	0.09	0.08	0.06	-	0.10	0.04	0.04	-	0.07	0.06	0.04	-	0.03	0.02	0.04	-
Shares Basic	38.4	-	38.6	39.5	39.4	-	38.9	38.8	38.7	-	38.4	38.3	38.2	-	38.2	38.8	39.6	-
Shares Diluted	40.5	-	40.5	41.1	41.6	-	40.8	40.6	40.6	-	40.4	40.7	40.0	-	39.6	39.8	40.4	-

Tax & Net
Income Tax Expense	1.3	2.2	1.5	1.7	1.0	1.9	1.6	0.8	0.5	1.6	1.3	0.7	0.5	1.1	0.5	0.4	0.7	1.0	1.4	1.2	(0.2)	0.2	1.1	(6.6)	0.2	0.1	0.1	0.0	0.1	-	0.0	0.0	-
Net Income From Continuing Ops	2.7	5.8	3.6	3.3	2.7	4.4	3.9	1.5	1.6	3.5	2.9	2.3	1.5	2.4	1.1	1.0	1.8
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	2.7	5.8	3.6	3.3	2.7	4.4	3.9	1.5	1.6	3.5	2.9	2.3	1.5	2.4	1.1	1.0	1.8
Net Income Attributable To Parent	2.6	5.6	3.5	3.2	2.6	4.3	3.9	1.5	1.6	3.5	2.9	2.3	1.5	2.4	1.1	1.0
Less: Minority Interest	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	-	0.0	0.0	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	2.6	5.6	3.5	3.2	2.6	4.3	3.9	1.5	1.6	3.5	2.9	2.3	1.5	2.4	1.1

Supplementary Data
EBITDA	11.9	29.6	6.0	5.4	10.5	24.8	6.0	4.0	8.5	21.7	4.6	3.2	6.7	-	-	-	5.6	-	-	-	3.9	-	-	-	6.7	-	-	-	3.7	-	-	-	-
EBIT	4.3	8.4	5.6	5.1	3.8	6.5	5.6	3.6	2.2	5.3	4.2	2.9	1.9	3.5	1.5	1.0	2.2	4.7	2.9